Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) announced this afternoon that it has closed its combination with drug developer Carmell having secured shareholder approval at a special meeting on July 11.
The combined company’s shares and warrants are expected to begin trading on the Nasdaq under the symbols “CTCX” and “CTCXW” on July 17.
The SPAC also divulged in an 8-K that it had better-than-average redemptions in the end with 81.5% of shares redeemed, leaving it with $29.5 million in trust.
It achieved this result thanks in part to a non-redemption agreement and forward purchase agreement it signed earlier this week through which Meteora Capital Partners agreed to hold onto 9.5% of its equity through close. After expenses, Alpha Healthcare III expects Carmell to add $16.1 million to its balance sheet.
Some of that capital may be immediately put to work as the parties announced they had signed an LOI to acquire a commercial-stage biotech firm following close for $8 million in cash and $57 million in Carmell stock.
Alpha Healthcare III initially inked the $188 million merger with Carmell in January. Pittsburgh-based Carmell is developing a treatment platform to accelerate healing in bone fractures and soft tissue wounds.
ADVISORS
- Goodwin Procter LLP acted as legal counsel to Alpha Healthcare III.
- Troutman Pepper Hamilton Sanders LLP acted as legal counsel to Carmell.
Terms Tracker for the Week Ending May 3, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. The big news this week was that SPACs finally had a new IPO price with Churchill Capital Corp. IX’s $250 million offering on Thursday. SPACs...
Real estate marketplace Opendoor (NASDAQ:OPEN) is poised to be the latest de-SPAC to take a double-digit jump on earnings as it heads towards the weekend up +10%, having spiked as high as +27% earlier in the day. The movement comes as the former Social Capital II target reported progress towards profitability despite a high rates...
At the SPAC of Dawn Coinbase (NASDAQ:COIN) notched a surprise profit of over $1.5 billion in the first quarter of 2024, well exceeding estimates, demonstrating the powerful effect of publicly traded ETFs have had on crypto marketplaces since the start of the year. The result has pushed the company to bump up its own guidance...
Online casino and sports company Rush Street (NYSE:RSI) is up +18.4% in trading today on the back of a solid first quarter earnings release, bringing the company’s stock to its highest price since the second half of 2022 (currently $7.60). This makes it the latest in a line of 2020 and 2021 de-SPACs that have...
Mountain Crest V (NASDAQ:MCAG) broke a long dealmaking silence by SPACs this morning, albeit with a non-binding agreement to combine with Seoul-based diagnostic biotech firm CUBEBIO. The term sheet would give the company a $620 million pre-transaction equity value and help accelerate the rollout of CUBEBIO’s CEED-NOVUS cancer screening kit products. The company signed an...